Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
Kaiser
Jocelyn
J
D048868:Adaptor Proteins, Signal Transducing; D026683:Advisory Committees; D002455:Cell Division; D002986:Clinical Trials as Topic; D004268:DNA-Binding Proteins / Q000235:genetics / Q000502:physiology; D005602:France; D040181:Genetic Diseases, X-Linked / Q000628:therapy; D015316:Genetic Therapy / Q000009:adverse effects*; D005822:Genetic Vectors; D006801:Humans; D053631:Interleukin Receptor Common gamma Subunit; D060588:LIM Domain Proteins; D007938:Leukemia / Q000209:etiology* / Q000235:genetics; D008297:Male; D008667:Metalloproteins / Q000235:genetics / Q000502:physiology; D011518:Proto-Oncogene Proteins; D020395:Receptors, Interleukin-7 / Q000235:genetics; D012190:Retroviridae / Q000235:genetics; D012307:Risk Factors; D016511:Severe Combined Immunodeficiency / Q000628:therapy*; D016176:T-Lymphocyte Subsets / Q000502:physiology; D014481:United States; D014486:United States Food and Drug Administration
D048868:Adaptor Proteins, Signal Transducing; D004268:DNA-Binding Proteins; C507941:IL2RG protein, human; D053631:Interleukin Receptor Common gamma Subunit; D060588:LIM Domain Proteins; C085117:LMO2 protein, human; D008667:Metalloproteins; D011518:Proto-Oncogene Proteins; D020395:Receptors, Interleukin-7